NCT02240238 2025-01-22
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
NanoCarrier Co., Ltd.
Phase 1/2 Completed
Clinical Trials
5 trialsNCT02817113 2021-04-30
Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
Orient Europharma Co., Ltd.
Phase 1 Terminated
NCT03771820 2021-03-17
Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
NanoCarrier Co., Ltd.
Phase 2 Unknown
NCT02043288 2020-04-15
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
Orient Europharma Co., Ltd.
Phase 3 Completed
NCT00910741 2014-01-09
NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia
NanoCarrier Co., Ltd.
Phase 1/2 Completed